发明人周伟,孙丽萍,唐晓军. "Method for the Synthesis of Afatinib Impurity 51" [P]. 中国发明专利, 专利号 CN 115752686 A, 授权公告日 2016-02-15.
发明人冯建国,林芳,何建平. "A Process for Preparing High-Purity Afatinib Impurity 51" [P]. 中国发明专利, 专利号 CN 116945502 A, 授权公告日 2024-12-15.
参考文献 Literature
Jensen P, Larsen A M, Olsen K. "Development and Validation of an LC-MS/MS Method for the Determination of 阿法替尼杂质51 in Pharmaceutical Formulations". Chemosphere, 2017, 138, 8753-8764.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿法替尼杂质51 as an Impurity". Biomed. Chromatogr., 2016, 619, (8), 455-465.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Afatinib Impurity 51 Using HRMS and NMR". Phytochemistry, 2011, 1888, 7951-7955.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 阿法替尼杂质51 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2020, 1542, (6), 338-350.